COVID antiviral Molnupiravir to be tested in RECOVERY trial on hospitalised patients

The RECOVERY Trial was launched as an emergency response in March 2020 and has so far discovered three effective treatments for COVID-19 - the inexpensive steroid dexamethasone; the arthritis drug tocilizumab; and an artificial antibody treatment, now known as Ronapreve.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fPulyN
via IFTTT